Most bought healthcare stocks in Q1 2018
See which Healthcare stocks institutional investors increased the most in Q1 2018, measured as net growth in reported share positions from Q4 2017 into Q1 2018. Notable additions at the top of this list include TEVA PHARMACEUTICAL-SP ADR (TEVA), CVS HEALTH CORP (CVS), ZOETIS INC (ZTS), PACIFIC BIOSCIENCES OF CALIF (PACB). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 24,253,674 | $341.64M | 1 | 3 | 0 | 2 | 6 |
| CVS | CVS HEALTH CORP | 10,589,398 | $463.77M | 1 | 5 | 3 | 0 | 9 |
| ZTS | ZOETIS INC | 4,182,023 | $455.39M | 2 | 2 | 1 | 0 | 5 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 3,956,880 | $7.92M | 0 | 1 | 0 | 1 | 1 |
| MRK | MERCK & CO. INC. | 3,855,504 | $170.63M | 0 | 7 | 2 | 3 | 11 |
| XRAY | DENTSPLY SIRONA INC | 3,301,501 | $19.35M | 2 | 2 | 0 | 1 | 5 |
| NTLA | INTELLIA THERAPEUTICS INC | 2,227,827 | $49.56M | 0 | 1 | 0 | 0 | 1 |
| ELV | ELEVANCE HEALTH INC | 2,035,119 | $399.85M | 0 | 2 | 5 | 1 | 8 |
| LLY | ELI LILLY & CO | 1,999,870 | -$46.50M | 0 | 5 | 1 | 0 | 6 |
| ABBV | ABBVIE INC | 1,735,391 | $163.03M | 1 | 1 | 7 | 0 | 11 |
| HOLX | HOLOGIC INC | 1,698,462 | -$17.83M | 1 | 2 | 1 | 0 | 4 |
| CERS | CERUS CORP | 1,687,611 | $16.73M | 0 | 1 | 0 | 0 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,551,863 | $121.69M | 1 | 1 | 1 | 0 | 3 |
| VCYT | VERACYTE INC | 1,372,530 | $5.74M | 0 | 1 | 1 | 0 | 2 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 1,363,814 | -$2.45M | 0 | 2 | 0 | 0 | 2 |
| EXAS | EXACT SCIENCES CORP | 1,298,001 | $52.35M | 1 | 0 | 0 | 0 | 1 |
| MD | PEDIATRIX MEDICAL GROUP INC | 1,296,682 | $74.24M | 0 | 1 | 0 | 0 | 1 |
| DVA | DAVITA INC | 1,084,830 | -$171.84M | 1 | 0 | 0 | 1 | 2 |
| CAH | CARDINAL HEALTH INC | 1,017,024 | $81.84M | 0 | 3 | 2 | 1 | 6 |
| SRNE | SORRENTO THERAPEUTICS INC | 875,163 | $4.60M | 1 | 0 | 1 | 0 | 2 |
| INVA | INNOVIVA INC | 863,320 | $21.35M | 0 | 2 | 0 | 0 | 2 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 831,600 | $71.99M | 0 | 1 | 0 | 0 | 1 |
| MCRB | SERES THERAPEUTICS INC | 747,822 | -$1.61M | 0 | 1 | 1 | 0 | 2 |
| AKBA | AKEBIA THERAPEUTICS INC | 697,900 | -$3.07M | 0 | 1 | 0 | 0 | 1 |
| CTLT | CATALENT INC | 671,176 | $27.53M | 1 | 1 | 1 | 0 | 3 |
| ENZ | ENZO BIOCHEM INC | 641,100 | -$2.72M | 0 | 1 | 0 | 0 | 1 |
| RDNT | RADNET INC | 597,056 | $14.64M | 0 | 1 | 0 | 0 | 1 |
| GRFS | GRIFOLS SA-ADR | 564,488 | $236.47M | 0 | 2 | 0 | 0 | 2 |
| VCEL | VERICEL CORP | 535,692 | $5.99M | 0 | 1 | 0 | 0 | 1 |
| CDMO | AVID BIOSERVICES INC | 516,600 | $1.51M | 1 | 0 | 0 | 0 | 1 |
| BIIB | BIOGEN INC | 513,171 | $133.51M | 1 | 3 | 0 | 2 | 5 |
| CUE | CUE BIOPHARMA INC | 500,000 | $7.03M | 1 | 0 | 0 | 0 | 1 |
| CNC | CENTENE CORP | 490,751 | $58.75M | 0 | 3 | 0 | 0 | 3 |
| AMGN | AMGEN INC | 469,528 | $63.38M | 0 | 4 | 4 | 1 | 9 |
| EHC | ENCOMPASS HEALTH CORP | 411,810 | $23.66M | 1 | 1 | 0 | 0 | 2 |
| HCSG | HEALTHCARE SERVICES GROUP | 405,077 | $17.11M | 1 | 2 | 0 | 0 | 3 |
| ANAB | ANAPTYSBIO INC | 391,850 | $41.21M | 1 | 0 | 1 | 0 | 2 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 371,600 | $1.72M | 0 | 1 | 0 | 0 | 1 |
| AMRN | AMARIN CORP PLC -ADR | 359,735 | -$1.16M | 0 | 1 | 0 | 0 | 1 |
| BRKR | BRUKER CORP | 357,000 | $9.53M | 0 | 1 | 0 | 0 | 1 |
| HAE | HAEMONETICS CORP/MASS | 342,400 | $39.78M | 0 | 1 | 0 | 0 | 1 |
| PODD | INSULET CORP | 336,300 | $40.84M | 0 | 1 | 0 | 0 | 1 |
| LGND | LIGAND PHARMACEUTICALS | 314,994 | $53.42M | 0 | 1 | 0 | 0 | 1 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | 312,000 | $8.03M | 0 | 1 | 0 | 0 | 1 |
| EBS | EMERGENT BIOSOLUTIONS INC | 283,000 | $24.70M | 0 | 1 | 0 | 0 | 1 |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 277,600 | $12.87M | 0 | 1 | 0 | 0 | 1 |
| RVP | RETRACTABLE TECHNOLOGIES INC | 277,300 | $370.00K | 0 | 1 | 0 | 0 | 1 |
| CPRX | CATALYST PHARMACEUTICALS INC | 275,400 | -$1.03M | 0 | 1 | 0 | 0 | 1 |
| SAGE | SAGE THERAPEUTICS INC | 269,069 | $43.26M | 0 | 1 | 0 | 0 | 1 |
| ITCI | INTRA-CELLULAR THERAPIES INC | 266,686 | $9.39M | 1 | 0 | 1 | 0 | 2 |
Frequently asked questions about Most bought healthcare stocks in Q1 2018
What are the most bought Healthcare stocks in Q1 2018?
The most bought healthcare stocks in Q1 2018 are those with the largest increase in reported share counts across institutional investors compared to Q4 2017, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q1 2018?
Among filers in this sector, net additions were largest in companies such as TEVA PHARMACEUTICAL-SP ADR (TEVA), CVS HEALTH CORP (CVS), ZOETIS INC (ZTS), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2017).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.